SE9003904D0 - Method for the manufacture of a pharmaceutical dosage form - Google Patents

Method for the manufacture of a pharmaceutical dosage form

Info

Publication number
SE9003904D0
SE9003904D0 SE9003904A SE9003904A SE9003904D0 SE 9003904 D0 SE9003904 D0 SE 9003904D0 SE 9003904 A SE9003904 A SE 9003904A SE 9003904 A SE9003904 A SE 9003904A SE 9003904 D0 SE9003904 D0 SE 9003904D0
Authority
SE
Sweden
Prior art keywords
manufacture
dosage form
pharmaceutical dosage
dosage units
granulation
Prior art date
Application number
SE9003904A
Other languages
English (en)
Swedish (sv)
Inventor
P J G Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9003904A priority Critical patent/SE9003904D0/xx
Publication of SE9003904D0 publication Critical patent/SE9003904D0/xx
Priority to YU182091A priority patent/YU182091A/sh
Priority to AT91920733T priority patent/ATE130188T1/de
Priority to HU9301672A priority patent/HUT64212A/hu
Priority to EP91920733A priority patent/EP0560822B1/de
Priority to CA002097175A priority patent/CA2097175A1/en
Priority to PCT/SE1991/000813 priority patent/WO1992010169A1/en
Priority to PL91299376A priority patent/PL168605B1/pl
Priority to ES91920733T priority patent/ES2079689T3/es
Priority to DK91920733.2T priority patent/DK0560822T3/da
Priority to JP50011592A priority patent/JP3239319B2/ja
Priority to DE69114721T priority patent/DE69114721T2/de
Priority to AU89309/91A priority patent/AU659114B2/en
Priority to IE422991A priority patent/IE914229A1/en
Priority to IS3789A priority patent/IS3789A7/is
Priority to PT99721A priority patent/PT99721A/pt
Priority to NO93932054A priority patent/NO932054L/no
Priority to FI932552A priority patent/FI932552A/fi
Priority to US08/166,167 priority patent/US5419918A/en
Priority to GR960400086T priority patent/GR3018685T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
SE9003904A 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form SE9003904D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form
YU182091A YU182091A (sh) 1990-12-07 1991-11-20 Postupak za proizvodnju oblika čvrste jedinične doze sa kontrolisanim oslobadjanjem
AU89309/91A AU659114B2 (en) 1990-12-07 1991-12-03 Method for the manufacture of a controlled release solid unit dosage form
ES91920733T ES2079689T3 (es) 1990-12-07 1991-12-03 Metodo para la fabricacion de una forma de dosificacion unitaria solida de liberacion controlada.
DE69114721T DE69114721T2 (de) 1990-12-07 1991-12-03 Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.
EP91920733A EP0560822B1 (de) 1990-12-07 1991-12-03 Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe
CA002097175A CA2097175A1 (en) 1990-12-07 1991-12-03 Method for the manufacture of a controlled release solid unit dosage form
PCT/SE1991/000813 WO1992010169A1 (en) 1990-12-07 1991-12-03 Method for the manufacture of a controlled release solid unit dosage form
PL91299376A PL168605B1 (pl) 1990-12-07 1991-12-03 Sposób wytwarzania doustnych form dawek o kontrolowanym wydzielaniu substancji czynnej PL
AT91920733T ATE130188T1 (de) 1990-12-07 1991-12-03 Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.
DK91920733.2T DK0560822T3 (da) 1990-12-07 1991-12-03 Fremgangsmåde til fremstilling af en fast enhedsdosisform med styret frigørelse
JP50011592A JP3239319B2 (ja) 1990-12-07 1991-12-03 医薬投与形態の製造法
HU9301672A HUT64212A (en) 1990-12-07 1991-12-03 Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
IE422991A IE914229A1 (en) 1990-12-07 1991-12-05 Method for the manufacture of a controlled release solid¹unit dosage form
IS3789A IS3789A7 (is) 1990-12-07 1991-12-06 Aðferð við framleiðslu lyfjaskammta í föstu formimeð tempraðri losun virks þáttar
PT99721A PT99721A (pt) 1990-12-07 1991-12-06 Processo para a preparacao de formas de dosagem unitarias solidas de libertacaocontrolada tendo como componente principal uma matriz de gel hidrofilo em que o agente capaz de formar gel e a hidroxipropil-metilcelulose
NO93932054A NO932054L (no) 1990-12-07 1993-06-04 Fremgangsmaate for fremstilling av en fast enhetsdoseringsform med regulert frigjoeringseffekt
FI932552A FI932552A (fi) 1990-12-07 1993-06-04 Foerfarande foer framstaellning av en fast enhet doseringsform foer reglerad utloesningen
US08/166,167 US5419918A (en) 1990-12-07 1993-12-10 Method for the manufacture of a controlled release solid unit dosage form
GR960400086T GR3018685T3 (en) 1990-12-07 1996-01-17 Method for the manufacture of a controlled release solid unit dosage form.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
SE9003904D0 true SE9003904D0 (sv) 1990-12-07

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form

Country Status (20)

Country Link
US (1) US5419918A (de)
EP (1) EP0560822B1 (de)
JP (1) JP3239319B2 (de)
AT (1) ATE130188T1 (de)
AU (1) AU659114B2 (de)
CA (1) CA2097175A1 (de)
DE (1) DE69114721T2 (de)
DK (1) DK0560822T3 (de)
ES (1) ES2079689T3 (de)
FI (1) FI932552A (de)
GR (1) GR3018685T3 (de)
HU (1) HUT64212A (de)
IE (1) IE914229A1 (de)
IS (1) IS3789A7 (de)
NO (1) NO932054L (de)
PL (1) PL168605B1 (de)
PT (1) PT99721A (de)
SE (1) SE9003904D0 (de)
WO (1) WO1992010169A1 (de)
YU (1) YU182091A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
RO112991B1 (ro) * 1992-09-18 1998-03-30 Yamanouchi Pharma Co Ltd Preparat tip hidrogel, cu eliberare sustinuta
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
MX2015014656A (es) * 2013-04-16 2016-03-01 Murray And Poole Entpr Ltd Formulaciones de liberacion prolongada de colchicina y metodos de uso de las mismas.
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CA1247852A (en) * 1983-12-20 1989-01-03 Akihiko Nomura Process for preventing agglomeration of powders
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
WO1988004922A1 (en) * 1986-12-25 1988-07-14 Teysan Pharmaceuticals Co., Ltd. Slowly soluble granule and persistently effective composite granule prepared therefrom
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
WO1992010169A1 (en) 1992-06-25
ES2079689T3 (es) 1996-01-16
PT99721A (pt) 1993-04-30
CA2097175A1 (en) 1992-06-08
YU182091A (sh) 1994-04-05
HU9301672D0 (en) 1993-09-28
EP0560822B1 (de) 1995-11-15
GR3018685T3 (en) 1996-04-30
IE914229A1 (en) 1992-06-17
NO932054D0 (no) 1993-06-04
AU8930991A (en) 1992-07-08
PL299376A1 (en) 1994-03-07
DE69114721T2 (de) 1996-04-18
FI932552A0 (fi) 1993-06-04
DE69114721D1 (de) 1995-12-21
HUT64212A (en) 1993-12-28
ATE130188T1 (de) 1995-12-15
FI932552A (fi) 1993-06-04
US5419918A (en) 1995-05-30
JPH06503310A (ja) 1994-04-14
EP0560822A1 (de) 1993-09-22
DK0560822T3 (da) 1996-03-11
IS3789A7 (is) 1992-06-08
AU659114B2 (en) 1995-05-11
JP3239319B2 (ja) 2001-12-17
PL168605B1 (pl) 1996-03-29
NO932054L (no) 1993-06-04

Similar Documents

Publication Publication Date Title
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
DK1027037T3 (da) Farmaceutisk præparat som indeholder clodronat som aktiv ingrediens og forkislet mikrokrystallinsk cellulose som excipiens
DE3480705D1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
ATE151764T1 (de) Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen
NL189898C (nl) Vaste, farmaceutische doseringsvorm voor de orale toediening alsmede werkwijze ter vervaardiging daarvan.
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
SE8901003D0 (sv) Snabbloesliga preparat
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
ATE232859T1 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
DK0744402T3 (da) Kaliumsalt af biphenylmethanderivat og medicin indeholdende samme
UY26509A1 (es) Bases pirrolicas sustituidas de mannich, procedimiento para su preparación, medicamentos que contienen estos compuestos, y uso del compuesto para la preparación de medicamentos.
RU97109989A (ru) Способ лечения вагинозов и вагинитов у беременных
MX9205204A (es) Composicion farmaceutica que comprende compuestos antagonistas del receptor 5-hidroxitriptamina